Journal
DRUG DELIVERY
Volume 27, Issue 1, Pages 431-448Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/10717544.2020.1736208
Keywords
Fibroin; nanoparticles; biomaterial; review; administrative route
Categories
Funding
- National Research Council of Thailand (NRCT) under the Royal Golden Jubilee (RGJ-ASEAN) [PHD/0234/2560]
- Naresuan University [R2561B009]
- Naresuan University Scholarship
- Naresuan University Scholarship for Oral Presentation
- RGJASEAN Grant
Ask authors/readers for more resources
Fibroin is a dominant silk protein that possesses ideal properties as a biomaterial for drug delivery. Recently, the development of fibroin nanoparticles (FNPs) for various biomedical applications has been extensively studied. Due to their versatility and chemical modifiability, FNPs can encapsulate different types of therapeutic compounds, including small and big molecules, proteins, enzymes, vaccines, and genetic materials. Moreover, FNPs are able to be administered both parenterally and non-parenterally. This review summaries basic information on the silk and fibroin origin and characteristics, followed by the up-to-date data on the FNPs preparation and characterization methods. In addition, their medical applications as a drug delivery system are in-depth explored based on several administrative routes of parenteral, oral, transdermal, ocular, orthopedic, and respiratory. Finally, the challenges and suggested solutions, as well as the future outlooks of these systems are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available